Medical student’s invention aims to help infants with jaundice

Called the BiliRoo, the low-cost, non-electric device is designed to treat jaundice in newborns

5:00 AM

Author | Sam Page

A person wears a protype infant sling on the front of their body. The sling has a special window to allow light to reach the baby.
Courtesy of Daniel John

Daniel John’s dorm room was unlike most undergrad’s: littered with baby carriers and sewing kits.

Even with 10 chances, no one could guess that they were looking at medical device research and development.

“Relatives that knew how to sew taught me some of the basics, and those were some of the first devices that we iterated,” John said.

“For the clinical trials, I'm now working with manufacturers in South Asia.”

Daniel, now a student at the University of Michigan Medical School, is the inventor of BiliRoo, a potential low cost, non-electric device to treat jaundice in newborns.

Hyperbilirubinemia, the underlying cause of jaundice, affects tens of millions of newborns around the world every year.

BiliRoo is a wearable infant sling with a filter over the infant’s back, designed to allow therapeutic blue light to reach the baby while blocking harmful UV radiation.

The intention is that blue sunlight lowers high bilirubin levels, while the design of the infant sling enables the physiological benefits of “kangaroo care” (skin-to-skin contact) — hence the name, BiliRoo.

Typically, babies with hyperbilirubinemia are placed under an artificial blue light source.

John hopes BiliRoo can help infants in places where access to electricity or specialized medical equipment is limited.

John was born in Nepal and developed a passion for developing simple, inexpensive, easy-to-use medical devices.

“Growing up there, I saw a need for health care access — which is what made me interested in medicine in the first place — but then also a need for medical devices that are designed specifically for limited-resource settings that don't require electricity,” John said.

While still an undergraduate in mechanical engineering at Calvin University, John reached out to doctors from around the world and kept hearing about the neonatal jaundice problem.

After getting started on his prototype, John contacted Tina Slusher, M.D., Professor of Pediatric Critical Care Medicine at the University of Minnesota and an expert in the field.

She partnered with John on a feasibility study of BiliRoo published in Pediatric Research.

Next, BiliRoo will be tested in a clinical trial this summer.

In the meantime, the device has won design prizes and pitch competitions, including first place at the 2026 Michigan Business Challenge.

BiliRoo was additionally recognized as one of the top undergraduate inventions of 2025 by the National Inventors Hall of Fame & USPTO and as the top hardware of 2025 by the American Society of Mechanical Engineers.

Recently, BiliRoo won the Southwest Pediatric Device Consortium Prize at the Rice Business Plan Competition.

At U-M Medical School, John has joined the Global Health & Disparities Path of Excellence under the mentorship of Shane C. Quinonez, M.D., Clinical Associate Professor of Pediatrics at U-M Medical School.

He has also been working with Karl C. Desch, M.D., Clinical Associate Professor of Pediatrics.

“I plan to continue developing BiliRoo until it gets to the infants that need it the most,” John said.

“After BiliRoo, I would love to continue working on medical devices as a practicing physician. I know some physicians do a combination of clinical care and research. I would love to do something similar with medical device research and development."

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

U-M Medical School Invention Future Think Neonatology Neonatal Care Children's Health maternal fetal medicine maternal care obstetrics and gynecology C.S. Mott Children’s Hospital
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Shane Quinonez

Shane Quinonez, MD

Clinical Associate Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Dark blue kid's bedroom at night.
Health Lab

School night bedtime tips every parent should know

U-M pediatrician warns that if kids aren’t getting enough sleep, learning is difficult and other problems may arise. Learn how many hours of sleep kids need.
Health Lab

Back-to-school anxiety: 6 ways to fight the fear

Learn the signs of back to school anxiety and find six tips for helping your child cope with anxiety about school.
Light blue background with pencil, clock, calendar, ABC crayons, markers, paper, and glue
Health Lab

5 ways to prepare your child for kindergarten

Is your child ready for the transition to kindergarten? Lay a strong foundation and prepare for their first day with these 5 tips from the C.S. Mott Children's Hospital.
drawing of kid on ipad and chat gpt giving answers and teaching child
Health Lab

More teens are using AI: What parents should know

As more teens turn to tools like ChatGPT for their schoolwork, a doctor shares what parents should watch out for and how they can help their kids use AI wisely.
magnifier over book with two parents looking over it
Health Lab

Helping kids with ADHD thrive in school

ADHD impacts almost 1 in 11 children. Read how parents can recognize the signs and support your child in and out of the classroom
mom smiling with two kids
Health Lab

Rare genetic eye disease treated with gene therapy helps 2 children see again

Mia and Niko Spicer were diagnosed with Leber’s congenital amaurosis type 2, a rare genetic eye disease, and were treated with the gene therapy Luxturna to improve their vision.